These conditions include the presence of underlying structural cardiopulmonary diseases (chronic obstructive disease, pulmonary hypertension), anemia, advanced age, atrial fibrillation, female sex, and renal failure, all of which result in high levels of NT-proBNP. This evidence concerns the gene NPPB and pulmonary hypertension.